Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.

Ya ZhengJessica ChingChung Wah ChengWai Ching LamKam Leung ChanXuan ZhangPui Yan LamXing Yao WuLinda L D ZhongPei Hua CaoCho Wing LoPui Kuan CheongZhixiu LinMatthew KohJustin WuZhao-Xiang Bian

Published in: Chinese medicine (2021)

ClinicalTrial.gov identifier: NCT03457324. Registered 8 February 2018, https://clinicaltrials.gov/ct2/show/NCT03457324?term=NCT03457324&draw=2&rank=1.

Keyphrases

double blind
irritable bowel syndrome
placebo controlled
clinical trial
phase ii
phase iii
study protocol
phase ii study
preterm infants
computed tomography
image quality
dual energy
open label
gestational age
rectal cancer
pet ct
locally advanced